A kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy has a dominant inhibitory impact on CSF1R signalling

Amino acid substitutions in the kinase domain of the human CSF1R gene are associated with autosomal dominant adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). To model the human disease, we created a disease-associated mutation (pGlu631Lys; E631K) in the mouse Csf1r locus. Homozygous mutation (Csf1r(E631K/E631K)) phenocopied the Csf1r knockout, with prenatal mortality or severe postnatal growth retardation and hydrocephalus. Heterozygous mutation delayed the postnatal expansion of tissue macrophage populations in most organs. Bone marrow cells from Csf1r(E631K/+)mice were resistant to CSF1 stimulation in vitro, and Csf1r(E631K/+) mice were unresponsive to administration of a CSF1-Fc fusion protein, which expanded tissue macrophage populations in controls. In the brain, microglial cell numbers and dendritic arborisation were reduced in Csf1r(E631K/+ )mice, as in patients with ALSP. The microglial phenotype is the opposite of microgliosis observed in Csf1r(+/-) mice. However, we found no evidence of brain pathology or impacts on motor function in aged Csf1r(E631K/+) mice. We conclude that heterozygous disease-associated CSF1R mutations compromise CSF1R signalling. We speculate that leukoencephalopathy associated with dominant human CSF1R mutations requires an environmental trigger and/or epistatic interaction with common neurodegenerative disease-associated alleles.

Automated summary

Amino acid substitutions in the kinase domain of the human CSF1R gene are associated with ALSP. A disease-associated mutation was created in the mouse Csf1r locus to model the human disease. This mutation affected the production of tissue macrophages and microglial cells in the mouse brain.